Tags

Type your tag names separated by a space and hit enter

Laparoscopic Roux-en-Y gastric bypass with 2-metre long biliopancreatic limb for morbid obesity: technique and experience with the first 150 patients.
Obes Surg. 2005 Jan; 15(1):35-42.OS

Abstract

BACKGROUND

Laparoscopic Roux-en-Y gastric bypass (RYGBP) is being performed widely as a treatment of choice for morbid obesity. We present our method and experience with the first 150 consecutive cases of laparoscopic RYGBP with a 2-m long biliopancreatic limb (BP-limb).

METHODS

Between November 2001 and November 2003, a prospective analysis of 150 patients was performed identifying technical success and complications. Before surgery, patients underwent a strict multidisciplinary behavioral program. At operation the stomach was transected proximally with a linear stapler (60-mm, Endo-GIA) to create a prolongation of the esophagus (gastric tube) along the lesser curvature, resulting in a 40-50 ml pouch. Two meters of the proximal jejunum were bypassed (BP-limb), creating an antecolic Roux-en-Y gastro-jejunostomy to the posterior wall of the gastric tube using a 45-mm linear Endo-GIA stapler. The entero-anastomosis was created 50 cm below the gastro-jejunostomy, also with a 45-mm linear Endo-GIA.

RESULTS

Mean BMI was 50.0, and 78% of patients were females. With 100% follow-up, we found an EWL of 50% 6 months after surgery, gradually rising to 80% after 18 months. The mean operating time was 116 min for the first 50 cases and decreased to 82 min for the last 50 cases. Intestinal leakage occurred in 5 patients (3%) and bleeding in 5 (3%). Most of these complications occurred in the first 50 cases, and all but one were treated successfully with an early laparoscopic re-operation. Marginal ulcers were found in 16.6% of patients. No internal hernias have occurred.

CONCLUSION

The operation demands advanced laparoscopic skills, but technically it is relatively simple and has an acceptable complication rate. Short-term results regarding excess weight loss are at least comparable to the RYGBP with a long alimentary limb.

Links

Aggregator Full Text

Authors+Show Affiliations

Leifsson BG
Department of Surgery, Landspítali University Hospital, Reykjavik, Iceland.
Gislason HG
No affiliation info available

MeSH

AdolescentAdultAnastomosis, Roux-en-YBiliopancreatic DiversionBody Mass IndexCombined Modality TherapyEvaluation Studies as TopicFemaleFollow-Up StudiesGastric BypassHumansLaparoscopyMaleMiddle AgedObesity, MorbidPostoperative ComplicationsProspective StudiesRisk AssessmentSeverity of Illness IndexSuturesTreatment OutcomeWeight Loss

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

15760497

Citation

Leifsson, Björn Geir, and Hjörtur Georg Gislason. "Laparoscopic Roux-en-Y Gastric Bypass With 2-metre Long Biliopancreatic Limb for Morbid Obesity: Technique and Experience With the First 150 Patients." Obesity Surgery, vol. 15, no. 1, 2005, pp. 35-42.
Leifsson BG, Gislason HG. Laparoscopic Roux-en-Y gastric bypass with 2-metre long biliopancreatic limb for morbid obesity: technique and experience with the first 150 patients. Obes Surg. 2005;15(1):35-42.
Leifsson, B. G., & Gislason, H. G. (2005). Laparoscopic Roux-en-Y gastric bypass with 2-metre long biliopancreatic limb for morbid obesity: technique and experience with the first 150 patients. Obesity Surgery, 15(1), 35-42.
Leifsson BG, Gislason HG. Laparoscopic Roux-en-Y Gastric Bypass With 2-metre Long Biliopancreatic Limb for Morbid Obesity: Technique and Experience With the First 150 Patients. Obes Surg. 2005;15(1):35-42. PubMed PMID: 15760497.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Laparoscopic Roux-en-Y gastric bypass with 2-metre long biliopancreatic limb for morbid obesity: technique and experience with the first 150 patients. AU - Leifsson,Björn Geir, AU - Gislason,Hjörtur Georg, PY - 2005/3/12/pubmed PY - 2005/4/6/medline PY - 2005/3/12/entrez SP - 35 EP - 42 JF - Obesity surgery JO - Obes Surg VL - 15 IS - 1 N2 - BACKGROUND: Laparoscopic Roux-en-Y gastric bypass (RYGBP) is being performed widely as a treatment of choice for morbid obesity. We present our method and experience with the first 150 consecutive cases of laparoscopic RYGBP with a 2-m long biliopancreatic limb (BP-limb). METHODS: Between November 2001 and November 2003, a prospective analysis of 150 patients was performed identifying technical success and complications. Before surgery, patients underwent a strict multidisciplinary behavioral program. At operation the stomach was transected proximally with a linear stapler (60-mm, Endo-GIA) to create a prolongation of the esophagus (gastric tube) along the lesser curvature, resulting in a 40-50 ml pouch. Two meters of the proximal jejunum were bypassed (BP-limb), creating an antecolic Roux-en-Y gastro-jejunostomy to the posterior wall of the gastric tube using a 45-mm linear Endo-GIA stapler. The entero-anastomosis was created 50 cm below the gastro-jejunostomy, also with a 45-mm linear Endo-GIA. RESULTS: Mean BMI was 50.0, and 78% of patients were females. With 100% follow-up, we found an EWL of 50% 6 months after surgery, gradually rising to 80% after 18 months. The mean operating time was 116 min for the first 50 cases and decreased to 82 min for the last 50 cases. Intestinal leakage occurred in 5 patients (3%) and bleeding in 5 (3%). Most of these complications occurred in the first 50 cases, and all but one were treated successfully with an early laparoscopic re-operation. Marginal ulcers were found in 16.6% of patients. No internal hernias have occurred. CONCLUSION: The operation demands advanced laparoscopic skills, but technically it is relatively simple and has an acceptable complication rate. Short-term results regarding excess weight loss are at least comparable to the RYGBP with a long alimentary limb. SN - 0960-8923 UR - https://www.unboundmedicine.com/medline/citation/15760497/Laparoscopic_Roux_en_Y_gastric_bypass_with_2_metre_long_biliopancreatic_limb_for_morbid_obesity:_technique_and_experience_with_the_first_150_patients_ L2 - https://dx.doi.org/10.1381/0960892052993396 DB - PRIME DP - Unbound Medicine ER -